Tevard Biosciences

Tevard Biosciences is a biotechnology company focused on developing innovative tRNA-based gene therapies aimed at curing rare genetic diseases, particularly those caused by nonsense mutations. Founded by a team including MIT molecular biologist Professor Harvey Lodish and parents of children with Dravet syndrome, the company seeks to provide durabl... e cures for conditions such as Duchenne muscular dystrophy and dilated cardiomyopathy. Their unique platform allows for broad applicability across various genetic disorders, targeting genes of any size without the risk of overexpression. Tevard's intended clients include patients suffering from rare genetic diseases and their families, as well as the broader medical community seeking effective treatment options.Read More